Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus

Suzanne Cole; Alice Walsh; Xuefeng Yin; Mihir Wechalekar; Malcolm Smith; Susan Proudman; Douglas Veale; Ursula Fearon; Costantino Pitzalis; Christopher Chiu; Michael Sharp; John Alvarez; Ian Anderson; Loui Madakamutil; Sunil Nagpal; Yanxia Guo

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus

Suzanne Cole, Alice Walsh, Xuefeng Yin, Mihir Wechalekar, Malcolm Smith, Susan Proudman, Douglas Veale, Ursula Fearon, Costantino Pitzalis, Christopher Chiu, Michael Sharp, John Alvarez, Ian Anderson, Loui Madakamutil, Sunil Nagpal, Yanxia Guo

College of Medicine and Public Health

Research output: Contribution to conference › Paper › peer-review

Original language	English
Publication status	Published - 2018
Event	Immunology 2018 - Duration: 4 May 2018 → …

Conference

Conference	Immunology 2018
Period	4/05/18 → …

Cite this

Cole, S., Walsh, A., Yin, X., Wechalekar, M., Smith, M., Proudman, S., Veale, D., Fearon, U., Pitzalis, C., Chiu, C., Sharp, M., Alvarez, J., Anderson, I., Madakamutil, L., Nagpal, S., & Guo, Y. (2018). Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus. Paper presented at Immunology 2018.

@conference{ffe14d393a6d4cbb8ccd3656eae122d6,

title = "Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus",

author = "Suzanne Cole and Alice Walsh and Xuefeng Yin and Mihir Wechalekar and Malcolm Smith and Susan Proudman and Douglas Veale and Ursula Fearon and Costantino Pitzalis and Christopher Chiu and Michael Sharp and John Alvarez and Ian Anderson and Loui Madakamutil and Sunil Nagpal and Yanxia Guo",

year = "2018",

language = "English",

note = "Immunology 2018 ; Conference date: 04-05-2018",

}

Cole, S, Walsh, A, Yin, X, Wechalekar, M, Smith, M, Proudman, S, Veale, D, Fearon, U, Pitzalis, C, Chiu, C, Sharp, M, Alvarez, J, Anderson, I, Madakamutil, L, Nagpal, S & Guo, Y 2018, 'Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus', Paper presented at Immunology 2018, 4/05/18.

TY - CONF

T1 - Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus

AU - Cole, Suzanne

AU - Walsh, Alice

AU - Yin, Xuefeng

AU - Wechalekar, Mihir

AU - Smith, Malcolm

AU - Proudman, Susan

AU - Veale, Douglas

AU - Fearon, Ursula

AU - Pitzalis, Costantino

AU - Chiu, Christopher

AU - Sharp, Michael

AU - Alvarez, John

AU - Anderson, Ian

AU - Madakamutil, Loui

AU - Nagpal, Sunil

AU - Guo, Yanxia

PY - 2018

Y1 - 2018

UR - http://www.jimmunol.org/content/200/1_Supplement/175.18/tab-article-info

M3 - Paper

T2 - Immunology 2018

Y2 - 4 May 2018

ER -

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus

Conference

Other files and links

Cite this